INDENTURE Dated as of December 9, 2016 Among CATALENT PHARMA SOLUTIONS, INC. the Guarantors listed herein DEUTSCHE TRUSTEE COMPANY LIMITED as Trustee DEUTSCHE BANK AG, LONDON BRANCH as Principal Paying Agent and DEUTSCHE BANK LUXEMBOURG S.A. as...Indenture • December 12th, 2016 • Catalent, Inc. • Pharmaceutical preparations • New York
This INDENTURE, dated as of December 9, 2016, is among Catalent Pharma Solutions, Inc. (the “Issuer”), a Delaware corporation, the Guarantors (as defined herein) listed on the signature pages hereto, Deutsche Trustee Company Limited, as trustee (the “Trustee”), Deutsche Bank AG, London Branch, as the principal paying agent, and Deutsche Bank Luxembourg S.A., as transfer agent and registrar.
AMENDMENT NO. 2 TO AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • December 12th, 2016 • Catalent, Inc. • Pharmaceutical preparations • New York
AMENDMENT NO. 2 TO AMENDED AND RESTATED CREDIT AGREEMENT, dated as of December 9, 2016 (this “Amendment”), by and among CATALENT PHARMA SOLUTIONS, INC., a Delaware corporation (the “Borrower”), PTS INTERMEDIATE HOLDINGS LLC, a Delaware limited liability company (“Holdings”), MORGAN STANLEY SENIOR FUNDING, INC. (“MSSF”), as Administrative Agent (in such capacity, the “Administrative Agent”), Collateral Agent and Swing Line Lender and the Lenders party hereto.
